DIATHEVA - Biomanufacturing of innovative diagnostics and reagents

Library / Papers / Genetic diseases-Laminopathies

Genetic diseases-Laminopathies

Documents

No Title File Type Download
1 A High Throughput Phenotypic Screening reveals compounds that counteract premature osteogenic differentiation of HGPS iPS-derived mesenchymal stem cells A High Throughput Phenotypic Screening reveals compounds that counteract premature osteogenic differentiation of HGPS iPS-derived mesenchymal stem cells
2 Rehabilitation requirements of camels and cows modern slaughter house for food safety management system (ISO 22000) during Hajj season 1434 H Rehabilitation requirements of camels and cows modern slaughter house for food safety management system (ISO 22000) during Hajj season 1434 H
3 Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities
4 A Novel Panel of Serum Biomarkers for MPM Diagnosis A Novel Panel of Serum Biomarkers for MPM Diagnosis
5 Lamins are rapamycin targets that impact human longevity: a study in centenarians Lamins are rapamycin targets that impact human longevity: a study in centenarians
6 Different prelamin A forms accumulate in human fibroblasts: a study in experimental models and progeria Different prelamin A forms accumulate in human fibroblasts: a study in experimental models and progeria
7 Prelamin A processing and functional effects in restrictive dermopathy Prelamin A processing and functional effects in restrictive dermopathy
8 Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis
9 Prelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle Prelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle
10 N6‐isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A N6‐isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A
11 Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome
12 Progeroid laminopathy with restrictive dermopathy-like features caused by an isodisomic LMNA mutation Progeroid laminopathy with restrictive dermopathy-like features caused by an isodisomic LMNA mutation
13 The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression
14 Altered chromatin organization and SUN2 localization in mandibuloacral dysplasia are rescued by drug treatment Altered chromatin organization and SUN2 localization in mandibuloacral dysplasia are rescued by drug treatment
15 The mitochondrial transporter of ascorbic acid functions with high affinity in the presence of low millimolar concentrations of sodium and in the absence of calcium and magnesium The mitochondrial transporter of ascorbic acid functions with high affinity in the presence of low millimolar concentrations of sodium and in the absence of calcium and magnesium
16 Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria
17 High prevalence of laminopathies among patients with metabolic syndrome High prevalence of laminopathies among patients with metabolic syndrome
18 Mitotic Defects Lead to Pervasive Aneuploidy and Accompany Loss of RB1 Activity in Mouse LmnaDhe Dermal Fibroblasts Mitotic Defects Lead to Pervasive Aneuploidy and Accompany Loss of RB1 Activity in Mouse LmnaDhe Dermal Fibroblasts
19 Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy Reduced adipogenic gene expression in fibroblasts from a patient with type 2 congenital generalized lipodystrophy
20 Skeletal Phenotype Of Mandibuloacral Dysplasia Associated With Mutations In ZMPSTE24 Skeletal Phenotype Of Mandibuloacral Dysplasia Associated With Mutations In ZMPSTE24
21 Induced Pluripotent Stem Cells Reveal Functional Differences Between Drugs Currently Investigated in Patients With Hutchinson-Gilford Progeria Syndrome Induced Pluripotent Stem Cells Reveal Functional Differences Between Drugs Currently Investigated in Patients With Hutchinson-Gilford Progeria Syndrome
22 Mandibuloacral dysplasia type A in childhood Mandibuloacral dysplasia type A in childhood
23 All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype
24 141st ENMC International Workshop Inaugural Meeting of the EURO-Laminopathies Project Nuclear Envelope-linked Rare Human Diseases: From Molecular Pathophysiology towards Clinical Applications 10–12 March 2006, Naarden, The Netherlands 141st ENMC International Workshop Inaugural Meeting of the EURO-Laminopathies Project Nuclear Envelope-linked Rare Human Diseases: From Molecular Pathophysiology towards Clinical Applications 10–12 March 2006, Naarden, The Netherlands
25 Lamin A, An Activator of Longevity/Anti-Aging SIRT1 Protein Lamin A, An Activator of Longevity/Anti-Aging SIRT1 Protein
26 Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation
27 An overview of new translational, clinical and therapeutic perspectives in laminopathies and other nuclear envelope-related diseases An overview of new translational, clinical and therapeutic perspectives in laminopathies and other nuclear envelope-related diseases
Company certified
ISO9001
Certified N.
IT05/0576
info@diatheva.com
Phone (+39) 0721 830605
Fax (+39) 0721 837154
 
website netcompany
P.IVA.01403060427

By navigating this website you provide your agreement to the use of cookies, which we use to improve your navigation experience and for statistical analysis. Read our Cookie Policy to learn more

Your Shopping Cart

 x 
Cart empty